Growth funding WhiteSpace Health has secured $18M in funding from Goldman Sachs Asset Management and Everstone Capital to accelerate its AI-driven Revenue Intelligence Platform, signaling readiness and budget for sales engagements around analytics and revenue cycle optimization.

Strategic leadership Board appointment of Halee Fischer-Wright as director and CEO signals governance depth and healthcare operations expertise, presenting an opportunity to engage around enterprise-scale BI, performance metrics, and hospital network efficiency.

AI driven Product focuses on machine learning, predictive analytics, and a health data warehouse within a SaaS BI solution, ideal for cross-sell to existing healthcare systems looking to enhance revenue cycle, operations analytics, and KPI visibility.

Mid-market target Company size and revenue range place WhiteSpace Health in the upper mid-market segment; sales motions can emphasize scalable BI for mid-sized hospitals and networks seeking robust analytics without large on-prem investments.

Strategic partnerships Investor backing and AI-first roadmap indicate openness to collaboration; position to explore co-sell with ecosystem players and expand go-to-market through cloud, data services, and healthcare IT partnerships.